1. Home
  2. XLO vs TOPS Comparison

XLO vs TOPS Comparison

Compare XLO & TOPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • TOPS
  • Stock Information
  • Founded
  • XLO 2016
  • TOPS 2000
  • Country
  • XLO United States
  • TOPS Greece
  • Employees
  • XLO N/A
  • TOPS N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • TOPS Marine Transportation
  • Sector
  • XLO Health Care
  • TOPS Consumer Discretionary
  • Exchange
  • XLO Nasdaq
  • TOPS Nasdaq
  • Market Cap
  • XLO 42.2M
  • TOPS 40.7M
  • IPO Year
  • XLO 2021
  • TOPS 2004
  • Fundamental
  • Price
  • XLO $0.69
  • TOPS $5.45
  • Analyst Decision
  • XLO Buy
  • TOPS
  • Analyst Count
  • XLO 1
  • TOPS 0
  • Target Price
  • XLO $4.00
  • TOPS N/A
  • AVG Volume (30 Days)
  • XLO 950.0K
  • TOPS 302.9K
  • Earning Date
  • XLO 08-07-2025
  • TOPS 08-08-2025
  • Dividend Yield
  • XLO N/A
  • TOPS N/A
  • EPS Growth
  • XLO N/A
  • TOPS N/A
  • EPS
  • XLO N/A
  • TOPS 1.09
  • Revenue
  • XLO $9,274,000.00
  • TOPS $86,127,000.00
  • Revenue This Year
  • XLO $300.08
  • TOPS $9.90
  • Revenue Next Year
  • XLO $1.87
  • TOPS N/A
  • P/E Ratio
  • XLO N/A
  • TOPS $5.06
  • Revenue Growth
  • XLO N/A
  • TOPS 3.83
  • 52 Week Low
  • XLO $0.62
  • TOPS $5.00
  • 52 Week High
  • XLO $1.70
  • TOPS $11.68
  • Technical
  • Relative Strength Index (RSI)
  • XLO 42.49
  • TOPS 42.62
  • Support Level
  • XLO $0.65
  • TOPS $5.68
  • Resistance Level
  • XLO $0.70
  • TOPS $9.74
  • Average True Range (ATR)
  • XLO 0.04
  • TOPS 1.25
  • MACD
  • XLO -0.01
  • TOPS -0.22
  • Stochastic Oscillator
  • XLO 19.51
  • TOPS 12.71

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About TOPS TOP Ships Inc.

TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.

Share on Social Networks: